Related Experiment Videos
[Pathogenetic differentiation of the bone superscan using bone marrow scintigraphy]
M Weckesser1, V G Müller-Mattheis, H Vosberg
1Urologische Klinik, Heinrich-Heine-Universität Düsseldorf, Deutschland.
Nuklearmedizin. Nuclear Medicine
|July 3, 1998
Summary
A prostatic carcinoma case shows advanced bone metastases. Bone marrow scintigraphy revealed peripheral marrow extension explaining the "superscan" findings in bone scintigraphy.
Area of Science:
- Oncology
- Nuclear Medicine
Background:
- Prostatic carcinoma is a common malignancy in older men.
- Bone metastases are a frequent complication, significantly impacting patient prognosis.
- Antiandrogenic therapy is a standard treatment for advanced prostate cancer.
Observation:
- A 54-year-old male patient with prostatic carcinoma presented with advanced bone metastases.
- Initial response to antiandrogenic therapy was observed.
- Progressive bone pain, particularly in the knee joints, indicated disease progression after three years.
Findings:
- Bone scintigraphy revealed a "superscan" pattern with increased uptake in the peripheral skeleton.
- Bone marrow scintigraphy demonstrated near-complete displacement of central bone marrow by metastatic disease.
- Peripheral bone marrow extension was identified as the cause of the observed scintigraphic findings.
Implications:
- This case highlights the importance of advanced imaging techniques in evaluating metastatic patterns.
- Understanding bone marrow involvement is crucial for interpreting bone scintigraphy findings in advanced cancer.
- Peripheral marrow extension may represent an aggressive metastatic phenotype in prostatic carcinoma.